Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Oncology Solid Tumor

Solid Tumor
Open Access Mucosal Melanoma Case Study

Promising response to oncolytic virus therapy in mucosal melanoma

Read more

Intralesional treatment with the oncolytic virus talimogene laherparepvec led to a complete local response in a patient with oral mucosal melanoma who was ineligible for other anticancer therapies.

Editor's Choice

Axillary management: less can be more

Open Access Breast Cancer Review

Management of the axilla in patients with breast cancer has evolved considerably over the past three decades, from routine clearance to complete omission in select patients. Explore the evidence that has shaped these practice changes.

Low-grade glioma in adolescents and young adults

Free for a limited time Glioma Review

25% of gliomas in adolescents and young adults are pediatric-type LGG. Should treatment in this older age group be the same as in children?

New PARP inhibitor shows promise in advanced ovarian cancer

22-05-2024 Ovarian Cancer News

Women with advanced ovarian cancer who respond to first-line chemotherapy could benefit from maintenance treatment with the PARP inhibitor senaparib, irrespective of their BRCA mutation status.

A challenging diagnosis: melanoma or clear cell sarcoma?

Open Access Clear-Cell Sarcoma Case Study

A case of clear cell sarcoma of soft tissue misdiagnosed as malignant melanoma underscores the need for an integrated diagnostic approach involving clinical, histopathological, and radiological evaluations.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

Latest News

New PARP inhibitor shows promise in advanced ovarian cancer

22-05-2024 Ovarian Cancer News

PARP inhibitors tied to increased thrombosis risk

10-05-2024 Adverse Effects of Cancer Therapy News

Plant-based diets linked to reduced risk for prostate cancer progression

03-05-2024 Prostate Cancer News

GLP-1 receptor agonists not associated with increased risk for thyroid cancer

02-05-2024 Incretin Mimetics News

No reduction in breast cancer recurrence with aspirin

30-04-2024 Breast Cancer News

Some reassurance on ICI use in pregnancy from VigiBase analysis

23-04-2024 Checkpoint Inhibitors News
Lung Cancer Clinical Trial Summary

At a glance: The KEYNOTE lung cancer trials

Read more

A quick guide to the KEYNOTE trials investigating the anti-PD-1 agent pembrolizumab in non-small-cell and small-cell lung cancer.

Developed by: Springer Medicine

Case Studies

Promising response to oncolytic virus therapy in mucosal melanoma

Open Access Mucosal Melanoma Case Study

Intralesional treatment with the oncolytic virus talimogene laherparepvec led to a complete local response in a patient with oral mucosal melanoma who was ineligible for other anticancer therapies.

A challenging diagnosis: melanoma or clear cell sarcoma?

Open Access Clear-Cell Sarcoma Case Study

A case of clear cell sarcoma of soft tissue misdiagnosed as malignant melanoma underscores the need for an integrated diagnostic approach involving clinical, histopathological, and radiological evaluations.

Hyalinizing trabecular tumor of the thyroid

Open Access Thyroid Cancer Case Study

Imaging, cytologic, histologic, and molecular investigations all contributed to the diagnosis of a rare case of HTT in a woman with an incidentally discovered mass in the left lobe of her thyroid gland.
Cancer Biomarker Video

Next-generation sequencing

Watch now

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. 

In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint. 

Supported by: Illumina, Inc., and Eli Lilly and Company

Prof. Andrew Beggs
Developed by: Springer Healthcare

Current Reviews

An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer

Geriatric Assessment REVIEW

Milwaukee, the most populous city in Wisconsin, has high rates of health inequities among segregated communities and neighborhoods with living conditions below the poverty level [ 1 – 3 ]. Many communities with individuals from historically and …

Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy

Melanoma REVIEW

The advent of modern therapeutics targeting BRAF and immune-checkpoint blockade has driven clinical improvement for patients with melanoma. Prior to the introduction of immune checkpoint inhibitors (ICIs) and targeted therapy, metastatic melanoma …

Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer

Open Access Pancreatic Cancer Review

Individuals with hereditary pancreatic cancer risk include high risk individuals (HRIs) with germline genetic susceptibility to pancreatic cancer (PC) and/or a strong family history of PC. Previously, studies have shown that PC surveillance in …

Low-grade glioma of the temporal lobe and tumor-related epilepsy in children

Epilepsy Review

Low-grade glioma (LGG) is the most common primary central nervous system tumor in children, representing about one-third of all brain tumors in the pediatric population [ 1 , 2 ]. These tumors are either grade 1 or 2 under the 2021 World Health …
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

CME & eLearning

Webinar (Link opens in a new window)

Lung Cancer

1.25 AMA PRA Category 1 Credit(s)™

A collaborative program highlighting the importance of molecular assessments and targeted treatment selection in people with biomarker-positive disease. Submit your questions for the experts now.

Supported by:
  • Roche and Illumina
Developed by: Springer Healthcare IME

Webcast | Videos | Cases (Link opens in a new window)

Thyroid Cancer

Identifying molecular biomarkers is crucial in determining the best targeted treatment options for your patients with advanced thyroid cancer.

Join our expert-led multi-format educational program that explores the continuing discovery of new genomic targets and delivers the latest research in molecular testing and the application of targeted therapies for thyroid cancer.

Start by watching our webcast and short vodcasts.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

eLearning | Interviews | Digital Treatment Map (Link opens in a new window)

NSCLC

1.0 AMA PRA Category 1 Credit(s)™

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.
Developed by: Springer Healthcare IME
NSCLC Podcast

Episode 7: A deep dive into ADAURA

Listen now

The ADAURA trial has, as of this year, demonstrated an overall survival benefit with the adjuvant use of osimertinib in people with resectable NSCLC. 

We take an in-depth look at the study with Dr. Luis Paz-Ares, who outlines the study findings, discusses the clinical implications, and addresses the pertinent questions raised by the trial.

Dr. Luis Paz-Ares

Further Reading

Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas

Open Access Melanoma Melanoma

A Comparison of Near-Infrared Autofluorescence Findings in Benign Versus Malignant Adrenal Tumors

Open Access Adrenal Cancer Endocrine Tumors

This was an institutional review board-approved prospective study of patients at a single tertiary center undergoing minimally invasive adrenalectomy by the senior author between October 2021 and May 2023. Decision for adrenalectomy was based on …

Predictors and surgical outcome of hemorrhagic metastatic brain malignancies

Open Access Metastasis Research

Intracerebral metastases represent the predominant form of brain malignancy in adults, with lung cancer, breast cancer, colorectal cancer, melanoma, and renal cell carcinoma posing the highest risk of metastasizing to the brain [ 1 ]. With …

A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database

Open Access Breast Cancer Original Article

Breast cancer is the most frequently diagnosed malignancy and is currently considered the second most common death-related malignancy in females [ 1 ]. Previous statistical studies have shown that 266,120 women in the United States suffer from …

Related topics

Free for a limited time Glioma Review

Low-grade glioma in adolescents and young adults

25% of gliomas in adolescents and young adults are pediatric-type LGG. Should treatment in this older age group be the same as in children?

Read more

Improving drug delivery in glioblastoma

Open Access Glioblastoma Review

Novel therapies for glioblastoma

Glioblastoma Review

Antiepileptic strategies for patients with brain tumors

Open Access Central Nervous System Cancer Review

Childhood cancer survivors benefit from getting active

08-02-2024 Pediatric Cancer News

CNS tumors: what should the neonatologist know?

Open Access CNS Tumors in Pediatrics Review
Open Access Thyroid Cancer Case Study

Hyalinizing trabecular tumor of the thyroid

Imaging, cytologic, histologic, and molecular investigations all contributed to the diagnosis of a rare case of HTT in a woman with an incidentally discovered mass in the left lobe of her thyroid gland.

Read more

GLP-1 receptor agonists not associated with increased risk for thyroid cancer

02-05-2024 Incretin Mimetics News

Insulinoma misidentified as schizophrenia

Insulinoma Case Study

Advances in radionuclide therapies for neuroendocrine tumors

Open Access Neuroendocrine Tumor Review

An unusual pancreatic neuroendocrine microtumor

Open Access Neuroendocrine Tumor Case Study

Follicular adenoma with a papillary architecture originating from an ectopic thyroid gland

Open Access Thyroid Disease Case Study
Sarcoma Review

Genetic predisposition to sarcoma: what should clinicians know?

Learn about when to test for cancer predisposition syndromes in patients with sarcoma, and the additional considerations for treatment and imaging in case of a positive result.

Read more

Consensus on the management of metastatic gastric cancer

Open Access Gastric Cancer Review

Insulinoma misidentified as schizophrenia

Insulinoma Case Study

ADCs in cancer: key data for currently approved agents

Open Access Cancer Therapy Review

Profound hypotension induced by ICI treatment

Open Access Adverse Effects of Cancer Therapy Case Study

Clinical practice guidelines for esophagogastric junction cancer

Open Access Gastroesophageal Junction Cancer Review
Open Access Adverse Effects of Cancer Therapy Case Study

Arrhythmia secondary to abiraterone treatment

A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.

Read more

Postoperative pembrolizumab improves OS in high-risk RCC

18-04-2024 Kidney Cancer News

ADCs in cancer: key data for currently approved agents

Open Access Cancer Therapy Review

Three-phase screening approach promising for prostate cancer

11-04-2024 Prostate Cancer News

Lymph node dissection in testicular cancer

Open Access Testicular Cancer Review

Exercise may serve as a painkiller for cancer survivors

22-02-2024 Lifestyle Modifications News
Open Access Breast Cancer Review

Axillary management: less can be more

Management of the axilla in patients with breast cancer has evolved considerably over the past three decades, from routine clearance to complete omission in select patients. Explore the evidence that has shaped these practice changes.

Read more

New PARP inhibitor shows promise in advanced ovarian cancer

22-05-2024 Ovarian Cancer News

Update on CDK4/6 inhibitors for breast cancer

Free for a limited time Breast Cancer Review

No reduction in breast cancer recurrence with aspirin

30-04-2024 Breast Cancer News

Vocal cord paralysis caused by metastasized endometrial cancer

Open Access Endometrial Cancer Case Study

ADCs in cancer: key data for currently approved agents

Open Access Cancer Therapy Review
Free for a limited time Head and Neck Cancer Review

Progress in immunotherapy for head and neck cancer

Surgery, radiotherapy, and chemotherapy are the primary treatments for advanced head and neck cancer, but checkpoint inhibition has recently shown promise. Delve into the efficacy and safety data for the key agents.

Read more

Management of dysphagia in head and neck cancer

Open Access Head and Neck Cancer Review

Stroke prevention measures warranted for head and neck cancer survivors

15-02-2024 Head and Neck Cancer News

An aggressive presentation of secretory carcinoma

Open Access Salivary Gland Cancer Case Study

Breast metastases in a male patient with nasopharyngeal carcinoma

Open Access Nasopharyngeal Cancer Case Study

Carcinosarcoma of the parotid gland

Open Access Salivary Gland Cancer Case Study
Open Access Clear-Cell Sarcoma Case Study

A challenging diagnosis: melanoma or clear cell sarcoma?

A case of clear cell sarcoma of soft tissue misdiagnosed as malignant melanoma underscores the need for an integrated diagnostic approach involving clinical, histopathological, and radiological evaluations.

Read more

Some reassurance on ICI use in pregnancy from VigiBase analysis

23-04-2024 Checkpoint Inhibitors News

Primary melanoma of the lung

Open Access Melanoma Case Study

Individualized neoantigen therapy may benefit people with resected melanoma

25-01-2024 Melanoma News

Treatment of melanoma brain and leptomeningeal metastases

Melanoma Review

Genetic counseling ‘should be considered’ for patients with early-onset MCC

05-01-2024 Merkel Cell Carcinoma News
Lung Cancer Clinical Trial Summary

At a glance: The KEYNOTE lung cancer trials

A quick guide to the KEYNOTE trials investigating the anti-PD-1 agent pembrolizumab in non-small-cell and small-cell lung cancer.

A challenging diagnosis of lung cancer

Open Access Lung Cancer Case Study

Bronchopleural fistula after neoadjuvant immunochemotherapy

Open Access Adverse Effects of Cancer Therapy Case Study

Severe megaloblastic anemia related to erlotinib

Open Access NSCLC Case Study

Trial reassures on SABR use in NSCLC patients with ILD

14-03-2024 NSCLC News

Managing malignant pleural effusion

Open Access Pleural Effusion Review
Image Credits